| Literature DB >> 30356709 |
Irina Sidorenko1, Varvara Turova2, Nikolai Botkin1, Laura Eckardt3, Ana Alves-Pinto2, Ursula Felderhoff-Müser3, Esther Rieger-Fackeldey4, Andrey Kovtanyuk2, Renée Lampe2.
Abstract
Intraventricular hemorrhage (IVH) is one of the most critical complications in the development of preterm infants. The likelihood of IVH is strongly associated with disturbances in cerebral blood flow (CBF) and with microvascular fragility in the germinal matrix (GM). The CBF value and its reactivity to changes in arterial carbon dioxide pressure (pCO 2 ) and mean arterial blood pressure (MABP) are relevant indicators in the clinical assessment of preterm infants. The objective of the present study is mathematical modeling of the influence of pCO 2 and MABP on CBF in immature brain, based on clinical data collected from 265 preterm infants with 23-30 gestational weeks. The model was adapted to the peculiarities of immature brain by taking into account the morphological characteristics of the GM capillary network and vascular reactivity, according to gestational and postnatal age. An analysis of model based values of CBF and its reactivity to changes in MABP and pCO 2 was performed separately for each gestational week and for the first two days of life both for preterm infants with and without IVH. The developed model for the estimation of CBF was validated against equivalent experimental measurements taken from the literature. A good agreement between the estimated values of CBF, as well as its reaction on changes in MABP and pCO 2 and the equivalent values obtained in experimental studies was shown.Entities:
Keywords: capillary wall tension; cerebral autoregulation; germinal matrix; gestational age; intraventricular hemorrhage
Year: 2018 PMID: 30356709 PMCID: PMC6189337 DOI: 10.3389/fneur.2018.00812
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.003
Obstetric characteristics of the control (no IVH) and risk (with IVH) groups.
| 23 | No | 12 | 2 | 2 | 2 | 520.83 ± 66.80 |
| With | 17 | 5 | 3 | 6 | 531.18 ± 79.78 | |
| 24 | No | 26 | 9 | 6 | 1 | 615.58 ± 103.70 |
| With | 24 | 14 | 9 | 2 | 657.71 ± 125.33 | |
| 25 | No | 19 | 10 | 0 | 2 | 688.94 ± 77.27 |
| With | 23 | 9 | 7 | 3 | 750.87 ± 100.79 | |
| 26 | No | 17 | 5 | 0 | 2 | 766.43 ± 68.71 |
| With | 20 | 16 | 9 | 0 | 822.00 ± 136.91 | |
| 27 | No | 13 | 6 | 2 | 4 | 902.31 ± 109.78 |
| With | 15 | 8 | 4 | 1 | 948.33 ± 226.45 | |
| 28 | No | 16 | 7 | 5 | 4 | 1017.2 ± 76.11 |
| With | 18 | 11 | 3 | 0 | 1157.5 ± 168.16 | |
| 29 | No | 13 | 5 | 6 | 1 | 1156.9 ± 67.09 |
| With | 11 | 6 | 1 | 1 | 1259.5 ± 213.76 | |
| 30 | No | 13 | 9 | 5 | 1 | 1274.6 ± 83.33 |
| With | 8 | 5 | 1 | 2 | 1456.2 ± 115.01 | |
| All | No | 129 | 53 | 26 | 17 | 838.59 ± 253.79 |
| With | 136 | 74 | 37 | 15 | 875.71 ± 300.51 | |
| All | All | 265 | 127 | 63 | 32 | 856.66 ± 278.94 |
The day of IVH diagnosis (number of diagnosed infants for each gestational week).
| 23 | 17 | 3 | 2 | 7 | 1 | 1 | 3 |
| 24 | 24 | 3 | 3 | 9 | 6 | 3 | |
| 25 | 23 | 3 | 4 | 7 | 5 | 1 | 3 |
| 26 | 20 | 3 | 10 | 2 | 3 | 2 | |
| 27 | 15 | 4 | 1 | 1 | 3 | 2 | 4 |
| 28 | 18 | 2 | 5 | 4 | 1 | 1 | 5 |
| 29 | 11 | 1 | 1 | 2 | 2 | 2 | 3 |
| 30 | 8 | 1 | 1 | 6 | |||
| All | 136 | 16 | 20 | 40 | 20 | 11 | 29 |
Baseline clinical parameters for infants with IVH before and after 5th postnatal day.
| Number of infants with | 107 (100%) | 29 (100%) |
| Twins | 29 (27.1%) | 8 (27.6%) |
| Triplets | 11 (10.3%) | 4 (13.8%) |
| CHARGE | 0 | 1 (3.4%) |
| Esophageal Atresia | 0 | 1 (3.4%) |
| Intrauterine Growth Retardation (IUGR) | 4 (3.7%) | 2 (6.9%) |
| Feto-Fetal Transfusion Syndrome (FFTS) | 3 (2.8%) | 1 (3.4%) |
| EPH Gestosis | 3 (2.8%) | 4 (13.8%) |
| 12 (11.2%) | 3 (10.3%) | |
| Lung Bleeding | 13 (12.2%) | 3 (10.3%) |
| Neonatal Bowel Perforation | 8 (7.5%) | 3 (10.3%) |
| Necrotizing Enterocolitis (NEC) | 8 (7.5%) | 4 (13.8%) |
| Disseminated Intravascular Coagulation (DIC) | 0 | 2 (6.9%) |
| Thrombocytopenia | 7 (6.5%) | 5 (17.2%) |
| Cardiopulmonary Adaptation | 4 (3.7%) | 4 (13.8%) |
| Cholestasis | 5 (4.7%) | 4 (13.8%) |
| Pulmonary Stenosis | 0 | 1 (3.4%) |
| Intubation | 89 (83.2%) | 25 (86.2%) |
| Sepsis | 56 (52.3%) | 14 (48.3%) |
| Death | 25 (23.4%) | 3 (10.3%) |
Volume fraction of germinal matrix (in% from total brain volume) (3).
| 5 | 3.3 | 2.3 | 1.7 | 1 | 0.7 | 0.3 | 0.1 | 0 |
Figure 1Schematic representation of the numerical model of CBF used in this study and of the procedure used in its validation.
Figure 2(A) Mean MABP for the control (blue lines) and risk (red lines) groups for the first day (dashed lines) and for the following days (solid lines); (B) polynomial approximation (lines without symbols) to the average pressure MABP obtained from the clinical records (lines with symbols) in the control group for the first day (green curves) and for the period after the first postnatal day (blue curves).
Figure 3(A) Dependence of CBF on MABP. The platea occurs around MABP = 30 mmHg. Different lines correspond to different values of pCO in mmHg [from bottom to top: 10, 20, 30, 40 (solid line corresponds to normocapnia), 50, 60, 70]. (B) Combined effect of MABP and pCO on CBF.
Figure 4(A) Resistance of the capillary layer with and without GM; (B) Wall tension in a single capillary of the GM and in another area of the brain.
Numerical values of CBF and its reactivity to pCO2 (R) and MABP (R).
| 23–30 | No | 129 | 1st | 8.39 ± 3.72 | 8.09 ± 1.76 | 2.59 ± 1.45 |
| 2nd | 10.62 ± 5.71 | 28.05 ± 2.81 | 1.95 ± 1.21 | |||
| 2nd-8th | 12.07 ± 5.99 | 28.52 ± 2.86 | 1.98 ± 1.12 | |||
| With | 136 | 1st | 9.02 ± 4.45 | 8.18 ± 1.88 | 2.67 ± 1.40 | |
| 2nd | 11.15 ± 7.08 | 28.20 ± 2.95 | 2.30 ± 1.20 | |||
| 2nd-8th | 12.99 ± 8.02 | 28.74 ± 2.92 | 2.22 ± 1.08 | |||
| All | 265 | 1st | 8.71 ± 4.1 | 8.14 ± 1.82 | 2.64 ± 1.42 | |
| 2nd | 10.92 ± 6.52 | 28.14 ± 2.89 | 2.15 ± 1.22 | |||
| 2nd-8th | 12.56 ± 7.15 | 28.64 ± 2.89 | 2.11±.10 |
Experimental values of CBF and its reactivity to pCO2 (R) and MABP (R) taken from the literature (9–14, 17, 22, 27).
| No | 1st | 8.4 (2–12 h) ( | ||
| 10.2 (12–24 h) ( | ||||
| 2nd | 11.5 ( | |||
| 16.5 ± 2.1 (pre-treated) ( | ||||
| 11.8 ± 1.2 (post-treated) ( | ||||
| All | 1st-2nd | 14 ± 1 (hypotensive) ( | ||
| 19 ± 1 (normotensive) ( | ||||
| 1st-4th | 13.6 (hypotensive) ( | 1.9 ( | ||
| 13.3 (normotensive) ( | ||||
| 2nd-8th | 12.51 ( | 32.7 ( | 1.0 ( | |
| 12.63 ( | 28.8 ( | |||
| 30 ( | ||||
| >7th | 8.5 ± 6.1 ( |
Effect of variations of input constant parameters on the model based CBF.
| 4.5 | 12.75 ± 7.22(+1.5%) | |
| 5 (in model) | 12.56 ± 7.15 | |
| 5.5 | 12.36 ± 7.07(-1.6%) | |
| 36 | 14.18 ± 7.88(+12.9%) | |
| 40 (in model) | 12.56 ± 7.15 | |
| 44 | 11.03 ± 6.46(-12.2%) | |
| μ [10−3 Pa s] | 2.61 | 13.85 ± 7.88(+10.3%) |
| 2.9 (in model) | 12.56 ± 7.15 | |
| 3.19 | 11.49 ± 6.54(-8.5%) |
Figure 5(A) Mean CBF for the first (dashed curves) and after the first day of life (solid curves); (B) mean absolute deviation of CBF from the mean value of the control group (CBF) for all postnatal days.
Figure 6Mean reactivity of CBF on pCO (A) and MABP (B) for the first (dashed curves) and after the first day of life (solid curves).